litlas
Log inCreate account

Angelo A. Izzo

Active 1990–2025

118
Papers
26,470
Citations
91
h-index
116
i10-index

Citations

Citations per year for Angelo A. Izzo1989: 1 citations1994: 6 citations1995: 3 citations1996: 3 citations1997: 9 citations1998: 11 citations1999: 39 citations2000: 39 citations2001: 66 citations2002: 66 citations2003: 82 citations2004: 102 citations2005: 173 citations2006: 138 citations2007: 143 citations2008: 190 citations2009: 188 citations2010: 166 citations2011: 190 citations2012: 217 citations2013: 169 citations2014: 176 citations2015: 143 citations2016: 244 citations2017: 211 citations2018: 185 citations2019: 821 citations2020: 1,166 citations2021: 1,360 citations2022: 1,103 citations2023: 686 citations2024: 1,219 citations2025: 443 citations2026: 3 citations1990–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,415 citing papers, 13.7% of this breakdownChina: 1,338 citing papers, 12.9% of this breakdownItaly: 855 citing papers, 8.3% of this breakdownUnited Kingdom: 513 citing papers, 5% of this breakdownIndia: 512 citing papers, 5% of this breakdownSpain: 342 citing papers, 3.3% of this breakdownCanada: 340 citing papers, 3.3% of this breakdownGermany: 332 citing papers, 3.2% of this breakdownBrazil: 302 citing papers, 2.9% of this breakdownAustralia: 280 citing papers, 2.7% of this breakdownIran: 280 citing papers, 2.7% of this breakdownFrance: 216 citing papers, 2.1% of this breakdown
0%13.7%Other 34.9%

Institutions

Fields

  • Medicine57.7%
  • Biochemistry, Genetics and Molecular Biology17.3%
  • Agricultural and Biological Sciences6.9%
  • Neuroscience5.2%
  • Pharmacology, Toxicology and Pharmaceutics4.2%
  • Immunology and Microbiology2.2%
  • Other6.5%

Topics

  • Cannabis and Cannabinoid Research7.6%
  • Phytochemicals and Antioxidant Activities2.5%
  • Gut microbiota and health1.8%
  • Neuroscience and Neuropharmacology Research1.7%
  • Diet, Metabolism, and Disease1.5%
  • GABA and Rice Research1.4%
  • Other83.5%

Coauthors

All papers

Open in search
  1. ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020

    Authors: Elliot Lilley, S. Clare Stanford, David Kendall, S P H Alexander, Giuseppe Cirino, James R. Docherty, Christopher H. George, Paul A. Insel, Angelo A. Izzo, Yong Ji, Reynold A. Panettieri, Christopher G. Sobey, Barbara Stefañska, Gary J. Stephens, Mauro Martins Teixeira, Amrita Ahluwalia - British Journal of Pharmacology 2020 cited by 1,134

  2. Planning experiments: Updated guidance on experimental design and analysis and their reporting III

    Authors: Michael J. Curtis, S P H Alexander, Giuseppe Cirino, Christopher H. George, David A. Kendall, Paul A. Insel, Angelo A. Izzo, Yong Ji, Reynold A. Panettieri, Hemal H. Patel, Christopher G. Sobey, S. Clare Stanford, Phil Stanley, Barbara Stefañska, Gary J. Stephens, Mauro Martins Teixeira, Nathalie Vergnolle, Amrita Ahluwalia - British Journal of Pharmacology 2022 cited by 510

  3. The Concise Guide to PHARMACOLOGY 2023/24: Enzymes

    Authors: S P H Alexander, Doriano Fabbro, Eamonn Kelly, Alistair Mathie, John A. Peters, Emma L. Veale, Jane F Armstrong, Elena Faccenda, Simon D Harding, Jamie A. Davies, Stephanie Annett, Detlev Boison, Kathryn Burns, Carmen Dessauer, Jürg Gertsch, Nuala A. Helsby, Angelo A. Izzo, Rennolds S. Ostrom, Andreas Papapetropoulos, Nigel J. Pyne, Susan Pyne, Tracy Robson, Roland Seifert, Johannes‐Peter Stasch, Csaba Szabó, Mario van der Stelt, Albert van der Vliet, Val J. Watts, Szu Shen Wong - British Journal of Pharmacology 2023 cited by 439

  4. Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology

    Authors: Steve P H Alexander, Richard Roberts, Brad R. S. Broughton, Christopher G. Sobey, Christopher H George, S. Clare Stanford, Giuseppe Cirino, James R. Docherty, Mark A. Giembycz, Daniël Hoyer, Paul A. Insel, Angelo A. Izzo, Yong Ji, David J. MacEwan, Jonathan E. Mangum, Sue Wonnacott, Amrita Ahluwalia - British Journal of Pharmacology 2018 cited by 855

  5. Polyphenols: A concise overview on the chemistry, occurrence, and human health

    Authors: Alessandra Durazzo, Massimo Lucarini, Eliana B. Souto, Carla Cicala, Elisabetta Caiazzo, Angelo A. Izzo, Ettore Novellino, Antonello Santini - Phytotherapy Research 2019 cited by 783

  6. Gut Microbiota and Obesity: A Role for Probiotics

    Authors: Ludovico Abenavoli, Emidio Scarpellini, Carmela Colica, Luigi Boccuto, Bahare Salehi, Javad Sharifi‐Rad, Vincenzo Aiello, Barbara Romano, Antonino De Lorenzo, Angelo A. Izzo, Raffaele Capasso - Nutrients 2019 cited by 608

  7. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases

    Authors: Ludovico Abenavoli, Angelo A. Izzo, Nataša Milić, Carla Cicala, Antonello Santini, Raffaele Capasso - Phytotherapy Research 2018 cited by 455

  8. A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies

    Authors: Angelo A. Izzo, Sung Hoon‐Kim, Rajan Radhakrishnan, Elizabeth M. Williamson - Phytotherapy Research 2016 cited by 529

  9. Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals

    Authors: Elizabeth M. Williamson, Xinmin Liu, Angelo A. Izzo - British Journal of Pharmacology 2019 cited by 303

  10. Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

    Authors: Michael J. Curtis, Steve Alexander, Giuseppe Cirino, James R. Docherty, Christopher H George, Mark A. Giembycz, Daniël Hoyer, Paul A. Insel, Angelo A. Izzo, Yong Ji, David J. MacEwan, Christopher G. Sobey, S. Clare Stanford, Mauro Martins Teixeira, Sue Wonnacott, Amrita Ahluwalia - British Journal of Pharmacology 2018 cited by 1,359

  11. Best practice in research – Overcoming common challenges in phytopharmacological research

    Authors: Michael Heinrich, Giovanni Appendino, Thomas Efferth, Robert Fürst, Angelo A. Izzo, Oliver Kayser, John M. Pezzuto, Alvaro Viljoen - Journal of Ethnopharmacology 2019 cited by 553

  12. Nanoparticle Delivery Systems in the Treatment of Diabetes Complications

    Authors: Eliana B. Souto, Selma B. Souto, Joana R. Campos, Patrícia Severino, Tatiana N. Pashirova, L. Ya. Zakharova, Amélia M. Silva, Alessandra Durazzo, Massimo Lucarini, Angelo A. Izzo, Antonello Santini - Molecules 2019 cited by 227

  13. Neuroprotective effect of cannabidiol, a non‐psychoactive component fromCannabis sativa, on β‐amyloid‐induced toxicity in PC12 cells

    Authors: Teresa Iuvone, Giuseppe Esposito, Ramona Esposito, Rita Santamaria, Massimo Di Rosa, Angelo A. Izzo - Journal of Neurochemistry 2004 cited by 354

  14. Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation

    Authors: Luciano De Petrocellis, Pierangelo Orlando, Aniello Schiano Moriello, Gabriella Aviello, Colin Stott, Angelo A. Izzo, Vincenzo Di Marzo - Acta Physiologica 2011 cited by 319

  15. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

    Authors: Angelo A. Izzo, Francesca Borrelli, Raffaele Capasso, Vincenzo Di Marzo, Raphael Mechoulam - Trends in Pharmacological Sciences 2009 cited by 816

  16. Future directions for the discovery of natural product-derived immunomodulating drugs: an IUPHAR positional review

    Authors: Cherry L. Wainwright, Mauro Martins Teixeira, David L. Adelson, Fernão Castro Braga, Eric J. Buenz, Priscilla Rodrigues Valadares Campana, Bruno David, Keith B. Glaser, Yuka Harata‐Lee, Melanie‐Jayne R. Howes, Angelo A. Izzo, Pasquale Maffia, Alejandro M. S. Mayer, Claire Mazars, David Newman, Eimear Nic Lughadha, Rodrigo Maia de Pádua, Adriano M.C. Pimenta, John A.A. Parra, Zhipeng Qu, Hanyuan Shen, Michael Spedding, Jean‐Luc Wolfender - Pharmacological Research 2022 cited by 106

  17. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease

    Authors: Francesca Borrelli, Ines Fasolino, Barbara Romano, Raffaele Capasso, Francesco Maiello, Diana Coppola, Pierangelo Orlando, Giovanni Battista, Ester Pagano, Vincenzo Di Marzo, Angelo A. Izzo - Biochemical Pharmacology 2013 cited by 315

  18. The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells

    Authors: Giuseppe Esposito, Daniele De Filippis, Rosa Carnuccio, Angelo A. Izzo, Teresa Iuvone - Journal of Molecular Medicine 2005 cited by 250

  19. Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid

    Authors: Francesca Borrelli, Ester Pagano, Barbara Romano, Stefania Panzera, Francesco Maiello, Diana Coppola, Luciano De Petrocellis, Lorena Buono, Pierangelo Orlando, Angelo A. Izzo - Carcinogenesis 2014 cited by 217

  20. Green tea (Camellia sinensis) for the prevention of cancer

    Authors: Tommaso Filippini, Marcella Malavolti, Francesca Borrelli, Angelo A. Izzo, Susan J. Fairweather‐Tait, Markus Horneber, Marco Vinceti - Cochrane Database of Systematic Reviews 2020 cited by 325

  21. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer

    Authors: Gabriella Aviello, Barbara Romano, Francesca Borrelli, Raffaele Capasso, Laura Gallo, Fabiana Piscitelli, Vincenzo Di Marzo, Angelo A. Izzo - Journal of Molecular Medicine 2012 cited by 189

  22. The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis

    Authors: Barbara Romano, Francesca Borrelli, Ines Fasolino, Raffaele Capasso, Fabiana Piscitelli, M. G. Cascio, Roger G. Pertwee, Diana Coppola, L.M. Vassallo, Pierangelo Orlando, Vincenzo Di Marzo, Angelo A. Izzo - British Journal of Pharmacology 2013 cited by 175

  23. TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β‐catenin signalling

    Authors: Ester Pagano, Barbara Romano, Donatella Cicia, Fabio Arturo Iannotti, Tommaso Venneri, Giuseppe Lucariello, Maria Francesca Nanì, Fabio Cattaneo, Paola De Cicco, Maria DʼArmiento, Marcello De Luca, Ruggiero Lionetti, Stefania Lama, Paola Stiuso, Pietro Zoppoli, Geppino Falco, Silvia Marchianò, Stefano Fiorucci, Raffaele Capasso, Vincenzo Di Marzo, Francesca Borrelli, Angelo A. Izzo - British Journal of Pharmacology 2022 cited by 40

  24. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes

    Authors: S P H Alexander, Doriano Fabbro, Eamonn Kelly, Alistair Mathie, John A. Peters, Emma L. Veale, Jane F Armstrong, Elena Faccenda, Simon D Harding, Adam J Pawson, Christopher Southan, Jamie A. Davies, Stephanie Annett, Detlev Boison, Kathryn Burns, Carmen Dessauer, Jürg Gertsch, Nuala A. Helsby, Angelo A. Izzo, Doris Koesling, Rennolds S. Ostrom, Andreas Papapetropoulos, Nigel J. Pyne, Susan Pyne, Tracy Robson, Michael Russwurm, Roland Seifert, Johannes‐Peter Stasch, Csaba Szabó, Mario van der Stelt, Albert van der Vliet, Val J. Watts, Szu Shen Wong - British Journal of Pharmacology 2021 cited by 384